Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- University Hospitals Cleveland Medical Center
- Study ID
- NCT06597968
- Status
- Recruiting
Conditions
- Lung Nodule
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- AI Based CAD Software (qXR-Ln) — DEVICEAll x-ray images have already been obtained and will then be run through CAD software for secondary nodule detection
Study Details
chest x-rays will be analyzed by AI software for a secondary read of lung nodules. Chest x-rays will either be sent to the AI tool to be read or to radiologists to read. If the image is sent to the AI tool, the AI software will generate a report on if it detects a lung nodule or not. The image will then be sent to a radiologist to determine if there is agreement or disagreement with the AI tool.
Key Dates
- Start date
- Jun 24, 2025
- Status verified
- Jan 2026
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 45,991 participants (estimated)
Arms
- Arm: Image going through AI toolthese are the images going through the AI tool
- Arm: image not going through AI toolthese are the images not going through the AI tool
Primary Outcome Measure
number of patients with actionable lung nodule as measured by CT scan [ Time Frame: up to one year ]
Central Contacts
- Lauren Hahn216-844-9312
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Hospitals | Cleveland | Ohio | 44106 |
Find similar trials in Cleveland, OH
By research site
Related Studies
- SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based ClassifierNot Yet Recruiting · University of Utah · Salt Lake City, Utah